AIFD
TR EN    
Home Page » ABOUT US » Charter » Charter Amendments
Charter

16. AMENDMENTS TO THE CHARTER

The Charter of the Association may be amended by a decision of the General Assembly. To have the amendment made in the first meeting, 2/3 of the members must be present and vote favorably. This majority is not required in the second meeting; however attendance must not be less than twice the number of members of the Boards of Directors and Auditors, and any decision to amend the charter must be taken by a majority vote of 2/3 of the members present..

MEMBER LOGIN
İşletim sisteminiz Flash Ögeleri Desteklemiyor. Yüklemek için tıklayınız.
INSIDER AIFD
Our pharmaceutical industry, global competition and opportunities
SEARCH IN SITE
DID YOU KNOW THAT…? IMPORTANT TERMS SITE MAP USEFUL LINKS CONFIDENTIALITY-TERMS OF USE CONTACT
AbbottActelion AIFDAlcon Alexion İlaç Ticaret Ltd. Şti.Allergan İlaçları Ticaret A.Ş. AmgenAstellasAstraZeneca Bausch+Lomb Sağlık Optik Ürünleri Tic. A.Ş.Bayer Türk Kimya San. Ltd. Şti. Boehringer IngelheimBristol-Myers SquibbCelgeneChiesiDaiichi-SankyoEczacıbaşı-BaxterFerring Fresenius KabiGilead Sciences İlaç.Tic. Ltd. Şti.GlaxoSmithKlineIBSA İlaç San. ve Tic. Ltd. Şti.Intendis ISectionİ.E.UlagayJohnson&JohnsonLillyLundbeck İlaç Tic.Ltd. Şti. Merck SeronoMSD TürkiyeNestle Novartis Sağlık Ürünleri Novo NordiskNutricia Klinik BeslenmeOTHERSPfizer İlaçları Ltd. ŞtiRoche Müstahzarları San. A.Ş.Sanofi-aventisServier Takeda İlaçları Tic Ltd Şti U.C.B. Pharma
AİFD is a member of IFPMA – International Federation of Pharmaceutical Manufacturers and Associations and EFPIA (European Federation of Pharmaceutical Industries and Associations).    
© Association of Research-Based Pharmaceutical Companies Last Update : 02.02.2012
XHTML 1.1 CSS